| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/32587103_HAS_TOPIC_C0001675> <https://research.tib.eu/covid-19/entity/32587103_HAS_TOPIC_C0005525> <https://research.tib.eu/covid-19/entity/32587103_HAS_TOPIC_C0013154> <https://research.tib.eu/covid-19/entity/32587103_HAS_TOPIC_C0021054> <https://research.tib.eu/covid-19/entity/32587103_HAS_TOPIC_C0026062> <https://research.tib.eu/covid-19/entity/32587103_HAS_TOPIC_C0032310> <https://research.tib.eu/covid-19/entity/32587103_HAS_TOPIC_C0033522> <https://research.tib.eu/covid-19/entity/32587103_HAS_TOPIC_C0086287> <https://research.tib.eu/covid-19/entity/32587103_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/32587103_HAS_TOPIC_C0086582> <https://research.tib.eu/covid-19/entity/32587103_HAS_TOPIC_C0205847> <https://research.tib.eu/covid-19/entity/32587103_HAS_TOPIC_C0206750> <https://research.tib.eu/covid-19/entity/32587103_HAS_TOPIC_C0295415> <https://research.tib.eu/covid-19/entity/32587103_HAS_TOPIC_C0393022> <https://research.tib.eu/covid-19/entity/32587103_HAS_TOPIC_C0393664> <https://research.tib.eu/covid-19/entity/32587103_HAS_TOPIC_C0732355> <https://research.tib.eu/covid-19/entity/32587103_HAS_TOPIC_C0751967> <https://research.tib.eu/covid-19/entity/32587103_HAS_TOPIC_C1314901> <https://research.tib.eu/covid-19/entity/32587103_HAS_TOPIC_C1527392> <https://research.tib.eu/covid-19/entity/32587103_HAS_TOPIC_C1615608> <https://research.tib.eu/covid-19/entity/32587103_HAS_TOPIC_C3694279> <https://research.tib.eu/covid-19/entity/32587103_HAS_TOPIC_C4046044> <https://research.tib.eu/covid-19/entity/32587103_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/32587103_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/32587103_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'From the Service de Neurologie, Pôle de Neurosciences Cliniques, APHM, Hôpital de la Timone, Aix Marseille Univ, France.\', \'From the Service de Neurologie, Pôle de Neurosciences Cliniques, APHM, Hôpital de la Timone, Aix Marseille Univ, France. bertrand.audoin@ap-hm.fr.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Audoin_Bertrand> <https://research.tib.eu/covid-19/entity/Boutiere_Clemence> <https://research.tib.eu/covid-19/entity/Demortiere_Sarah> <https://research.tib.eu/covid-19/entity/Maarouf_Adil> <https://research.tib.eu/covid-19/entity/Pelletier_Jean> <https://research.tib.eu/covid-19/entity/Perriguey_Marine> <https://research.tib.eu/covid-19/entity/Rico_Audrey>
?:doi	<https://research.tib.eu/covid-19/entity/e82510.1212/NXI.0000000000000825>
?:doi	e82510.1212/NXI.0000000000000825
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Observational_Study>
?:journal	Neurology(R) neuroimmunology & neuroinflammation
is ?:pmid of	<https://research.tib.eu/covid-19/entity/32587103>
?:pmid	<https://research.tib.eu/covid-19/entity/32587103>
?:pmid	32587103
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0393022_ADMINISTERED_TO_C0030705>
?:title	Extending rituximab dosing intervals in patients with MS during the COVID-19 pandemic and beyond?
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2020

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/32587103>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/32587103>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all